Lakewood-Amedex Biotherapeutics Inc. Common Stock
Lakewood-Amedex Biotherapeutics, Inc. engages in the development of novel antimicrobial therapies. Its anti-infective products targeted certain viral diseases like avian influenza, Epstein Barr Virus (EBV), and hepatitis B and C. The company was founded by Roderic Dale on July 11, 2006 and is headquartered in Bradenton, FL.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q2 | -2.75 | $0 | -$2M |
| 2026 Q1 | -2.00 | $0 | -$349,691 |